Search Result "XDR."
Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 88-91
Author(s): Zarir F. Udwadia, Tiyas Sen, Lancelot M. Pinto
XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 77-83
Author(s): Stephen H. Gillespie, Kasha Singh
Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5 Issue: 2 Year: 2010 Page: 109-114
Author(s): Leonard Amaral, Joseph Molnar
The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 73-91
Author(s): Robert C. Goldman, Kevin V. Plumley, Barbara E. Laughon
Stem Cells in MDR-TB and XDR - TB
Journal: Current Respiratory Medicine Reviews
Volume: 10 Issue: 4 Year: 2014 Page: 238-240
Author(s): Vijay K. Arora,Paramjit S. Dhot,P. Singhal
Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
Journal: Current Drug Targets
Volume: 9 Issue: 9 Year: 2008 Page: 816-819
Author(s): L. Amaral, M. Martins, M. Viveiros, J. Molnar, J. E. Kristiansen
An Experience with Delamanid in an XDR TB Case â Case Report
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2021 Page: 637-639
Author(s): Nimitha Mohan,Manharpreet Kaur,Lipika Singhal,Varinder Saini,Jagdish Chander
Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 96-114
Author(s): Veronique Dartois, Clifton E. Barry
Thioridazine: Alternative and Potentially Effective Therapy of the XDRTB Patient
Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 2 Year: 2011 Page: 130-132
Author(s): Leonard Amaral, Marta Martins, Miguel Viveiros
Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 110-117
Author(s): Marta Martins